Particle.news
Download on the App Store

Galicia’s RSV Vaccine Trial Draws Crowds in Weekend Push at Public Hospitals

Officials aim to recruit a vast adult cohort to produce evidence for possible calendar inclusion by 2028.

Overview

  • The regional health service invited all residents aged 18 and over to take part at 14 public hospitals, with participation also available at select health centers through the month.
  • Volunteers are randomized at enrollment, with roughly half receiving the authorized Abrysvo shot and half assigned to a control group by on‑screen software.
  • High turnout led to long queues and waits of up to about two hours in several sites, including Vigo’s Álvaro Cunqueiro, prompting added nursing staff and extended operating periods.
  • Roughly 20,000 people had already enrolled before the weekend drive, and organizers are targeting at least 150,000 participants, potentially up to 200,000.
  • This pragmatic study will use health records to track hospitalizations and real‑world impact, building on Galicia’s infant RSV program that sharply cut baby admissions.